| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |